CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
37.24
-0.33 (-0.88%)
At close: May 28, 2025, 3:59 PM
37.50
0.69%
After-hours: May 28, 2025, 04:40 PM EDT
-0.88% (1D)
| Bid | 37.25 |
| Market Cap | 3.22B |
| Revenue (ttm) | 36.12M |
| Net Income (ttm) | -385.66M |
| EPS (ttm) | -4.49 |
| PE Ratio (ttm) | -8.29 |
| Forward PE | -8.36 |
| Analyst | Buy |
| Ask | 37.96 |
| Volume | 1,448,826 |
| Avg. Volume (20D) | 2,019,925 |
| Open | 37.81 |
| Previous Close | 37.57 |
| Day's Range | 37.23 - 38.13 |
| 52-Week Range | 30.04 - 67.88 |
| Beta | 1.87 |
About CRSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-11.86%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
3 months ago
+14.33%
CRISPR Therapeutics shares are trading higher after Evercore ISI upgraded the stock from In-Line to Outperform and raised its price target from $60 to $99. Also, Morgan Stanley raised its price target from $30 to $32.
